产品名称：Human CD45 Antibody (Apamistamab, Research Use)
产品编号：NBR-0348
针对靶点：CD45
抗体药商品名：Apamistamab
抗体药描述：Apamistamab (Iomab-B) is a targeted therapy being developed for AML, comprised of a monoclonal antibody that is connected to radioactive material (making it a radiolabeled antibody).apamistamab (Iomab-B) is currently being studied in the SIERRA clinical trial. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: CD45
Synonyms: CD45; GP180; LCA; T200
Target Description: Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN.
Ensembl: ENSG00000081237 
Uniprot: P08575